Alternatively, however, CTSE activity levels could be studied according to a recent report, which showed that CTSE activity levels but not protein levels were associated with more advanced disease, recurrence, and prognosis in patients with breast cancer.31 This evidence concerns the gene CTSE and breast carcinoma.